基本信息
views: 1
Career Trajectory
Bio
Worked in several research groups throughout Europe (PharmD from University of Bologna 2012, Experimental thesis at Complutense University of Madrid and a second Master in Synthesis, Catalysis and Sustainable Chemistry from University of Lyon 1 2014) gaining considerable experience in the synthesis, purification and characterization of organic compounds.
In November 2015 joined the Radiopharmaceutical Sciences group at C2TN in Lisbon, as Marie Curie Fellow of MEDICIS-Promed (https://medicis.cern/medicis-promed). Completed the PhD in September 2020 on the development of "Clickable Radiocomplexes for Cancer Theranostics" working on the synthesis, characterization of clickable compounds, their radiolabelling with different isotopes of medical interest and their preclinical evaluation. After the PhD, I was working in the same group as a Post-Doc Researcher in the development of nanoparticles for theranostic applications.
Currently working as a Post-Doc Researcher of the University of Bern at the Radiopharmacy Lab of the Inselspital in the development and preclinical evaluation of novel radiotracers for in vivo imaging and therapy of tumors.
Research Interests
Papers共 13 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Alvaro Sarabia-Vallejo, Ana Molina, Monica Martinez-Orts,Alice D'Onofrio,Matteo Staderini,Maria Laura Bolognesi,M. Antonia Martin,Ana I. Olives,J. Carlos Menendez
MOLECULESno. 6 (2024)
Frontiers in medicine (2023)
Nuclear medicine and biology (2022): S188-S188
Load More
Author Statistics
#Papers: 13
#Citation: 79
H-Index: 5
G-Index: 8
Sociability: 4
Diversity: 2
Activity: 9
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn